Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berezin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Ultrasound : JCU|April 1, 1980
Ultrasound demonstration of uterus subseptusC R McArdle, A F Berezin
The American Journal of Cardiology|October 1, 1977
Symptomatic myocardial infarction without chest pain: prevalence and clinical courseB F Uretsky, D S Farquhar, A F Berezin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Pharmacologically based dosing of etoposide: a means of safely increasing dose intensityM J Ratain, R Mick, R L Schilsky, et al.
Cancer Research|March 15, 1993
Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancerR L Schilsky, L Janisch, F Berezin, et al.
Cancer Research|January 1, 1994
Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456)N J Vogelzang, R Mick, L Janisch, et al.
Obstetrics and Gynecology|March 1, 1989
Sonographic diagnosis of partial hydatidiform moleC Fine, A L Bundy, R S Berkowitz, et al.
Pharmacogenetics|February 1, 1996
Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and genderM J Ratain, R Mick, L Janisch, et al.
Clinical Pharmacology and Therapeutics|November 1, 1991
Paradoxical relationship between acetylator phenotype and amonafide toxicityM J Ratain, R Mick, F Berezin, et al.
Cancer Research|May 15, 1993
Phase I study of amonafide dosing based on acetylator phenotypeM J Ratain, R Mick, F Berezin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysisE E Vokes, M E Dolan, S Krishnasamy, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Ultrasound : JCU|April 1, 1980
Ultrasound demonstration of uterus subseptusC R McArdle, A F Berezin
The American Journal of Cardiology|October 1, 1977
Symptomatic myocardial infarction without chest pain: prevalence and clinical courseB F Uretsky, D S Farquhar, A F Berezin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Pharmacologically based dosing of etoposide: a means of safely increasing dose intensityM J Ratain, R Mick, R L Schilsky, et al.
Cancer Research|March 15, 1993
Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancerR L Schilsky, L Janisch, F Berezin, et al.
Cancer Research|January 1, 1994
Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456)N J Vogelzang, R Mick, L Janisch, et al.
Obstetrics and Gynecology|March 1, 1989
Sonographic diagnosis of partial hydatidiform moleC Fine, A L Bundy, R S Berkowitz, et al.
Pharmacogenetics|February 1, 1996
Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and genderM J Ratain, R Mick, L Janisch, et al.
Clinical Pharmacology and Therapeutics|November 1, 1991
Paradoxical relationship between acetylator phenotype and amonafide toxicityM J Ratain, R Mick, F Berezin, et al.
Cancer Research|May 15, 1993
Phase I study of amonafide dosing based on acetylator phenotypeM J Ratain, R Mick, F Berezin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysisE E Vokes, M E Dolan, S Krishnasamy, et al.
Pageof 1